Close
Nordic 9Nordic 9

Novalis Biotech (investor - Venture Capital)

Belgium noval.is
See something wrong or missing? Let us know
Offices:Gent

Novalis Biotech, founded by Wim Van Criekinge and Jan Van den Berghe, seeds biotechnology and life sciences related companies.

Average round investment:14.06M USD
Average number per year:2.3
Distribution: 2026 (3)2024 (3)2023 (2)2022 (4)2021 (1) See the entire list
Portfolio companies: Belgium TrinceSwitzerland Alithea GenomicsGermany Altavo GmbH See the entire list
Mostly invests in: Switzerland Switzerland (3) Health services (10)
See the entire list

Showing 3 of 14 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Novalis Biotech

Name Criteria
France Ouest Croissance
100%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, Manufacturing, Competitive Intelligence
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: France
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United States Day One Ventures
100%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Software Services, Manufacturing, Competitive Intelligence
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Germany, Sweden, France, Portugal, United Kingdom
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
United States MTech Capital
100%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Software Services, Competitive Intelligence
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Germany, France, United Kingdom
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
France ADEME Investissement
100%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Software Services, Manufacturing
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: France
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
France Elevation Capital Partners
100%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, Manufacturing, Competitive Intelligence
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: France
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United States Bleu Capital
100%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, Manufacturing, Competitive Intelligence
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Turkey Finberg
100%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, Hardware, Competitive Intelligence
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Sweden AxSol
100%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, Manufacturing, Competitive Intelligence
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Sweden
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States Anatoly Yakovenko
100%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Software Services, Manufacturing, Competitive Intelligence
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Switzerland, France, United Kingdom
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United Kingdom Celsius Industries
100%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Software Services, Manufacturing, Hardware, Competitive Intelligence
  • Similar business models: B2B, B2C (Retail), SAAS
  • Common investees countries: Switzerland, United Kingdom
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
Top